Combined high-dose sub-tenon triamcinolone, intravitreal bevacizumab, and laser photocoagulation for refractory diabetic macular edema: a pilot study
Retina, 03/30/2012Chan CKM et al.
Sustained reduction of central foveal thickness was achieved with triple therapy over the 1–year study period. Significant visual improvement was seen only in patients with worse baseline best–corrected visual acuity, but not in the triple therapy group as a whole. Significant side effects of intraocular pressure rise, ptosis, and cataractogenesis were encountered in the triple therapy group.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.